title: Cetuximab-dependent ADCC in cancer: dream or reality?
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ottaiano
authors.forename: Stefania
authors.initials: S
authors.lastname: Scala
authors.forename: Vincenzo Rosario
authors.initials: VR
authors.lastname: Iaffaioli
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000920:Antibody-Dependent Cell Cytotoxicity; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab